Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions

View source ↗

Summary

An observational real-world study in Indian patients is designed to evaluate the safety and effectiveness of vericiguat in chronic heart failure with reduced ej…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vericiguat (vericiguat)

Snippet

Sponsor: Bayer | Conditions: Chronic Heart Failure With Reduced Ejection Fraction, Worsening Chronic Heart Failure | Status: ACTIVE_NOT_RECRUITING